Daejeon, South Korea

Jong-Yup Kim

This inventor holds 1 USPTO granted patent. Top assignees: Lg Life Sciences, Limited, Yamanouchi Pharmaceutical Company Ltd.. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jong-Yup Kim. Retrieved from https://idiyas.com/inventor/jong-yup-kim-11wb88cl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 17.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Jong-Yup Kim: A Journey through Melanocortin Receptor Agonists

Introduction: Jong-Yup Kim, an esteemed inventor located in Daejeon, South Korea, has made significant contributions to the field of biochemistry with his innovative research and inventions. With a remarkable patent to his name, he has established himself as a notable figure in the scientific community.

Latest Patents: Jong-Yup Kim holds a patent for "Melanocortin receptor agonists." This invention pertains to a compound of formula 1, along with pharmaceutically acceptable salts, hydrates, solvates, or isomers, which are effective as agonists of the melanocortin receptor. It also includes an agonistic composition of melanocortin receptor featuring this compound as the active ingredient.

Career Highlights: Throughout his career, Jong-Yup Kim has worked with prestigious companies, including LG Life Sciences, Limited and Yamanouchi Pharmaceutical Company Ltd. These experiences have allowed him to apply his innovative ideas and collaborate with other brilliant minds in the industry.

Collaborations: Jong-Yup Kim has had the pleasure of collaborating with talented colleagues such as Koo Lee and Heui-Sul Park. Together, they have contributed to advancements in their field, fostering a collaborative environment that encourages innovation and scientific progress.

Conclusion: Jong-Yup Kim's contributions to the field through his patent on melanocortin receptor agonists showcase his dedication to innovation. His collaborations and experience in reputable companies highlight his commitment to advancing scientific research, making him a noteworthy inventor in the world of biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…